Sponsor Pipeline

Dren Bio Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
10
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07712562
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With…		 Primary endpoint(s) modified
Active Trials by Phase
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05475925 A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic… LGLL - Large Granular Lymphocytic Leukemia Recruiting
NCT07712562 A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With… Bone Marrow Failure Syndromes Not Yet Recruiting
Phase 1
NCT06999187 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or… Triple Negative Breast Cancer Recruiting
NCT06602232 A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo Alopecia Areata Active, Not Recruiting
Disease Areas
Leukemia (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Prostate Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Bladder Cancer (1) Ovarian Cancer (1)
Get alerts when Dren Bio's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free